FY17 biosite triage supplies - ncsuvendor: alere north AMERICAFY16 amount: $55,000.00
Ended Awarded Last action
- Contract number
- HHSI244201700022G
- Awardee
-
Abbott Rapid DX North America LLC UEI P782RNU1NNK3
- Awarding agency
-
Indian Health Service
Department of Health and Human Services
- Obligated
- $33,480
Award facts
- Opportunity
-
- M5Q52A04R1 Solicitation number
- Biosite Incorporated, a Division of Inverness Medical Innovations, Inc. Contract Award 05/15/2009 through 05/14/2014 Award Notice · Posted Oct 20, 2005
- Contract value 38% obligated
- $88,480.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lame Deer, MT, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$21,520 | |
| Funding Only Action | $25,000 | |
| Funding Only Action | $30,000 | |
| Original award | $0 |
About this award
This federal contract award is for the delivery of BIOSITE TRIAGE SUPPLIES to the Indian Health Service (IHS), a civilian agency under the U.S. Department of Health and Human Services. The contract was awarded to Abbott Rapid DX North America LLC, doing business as Alere North America, a subsidiary of Abbott Laboratories. The contract has a ceiling value of $88,480.42 and was awarded on October 3, 2016, with a completion date of September 30, 2017. The contract is a Firm Fixed Price Delivery Order placed under GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests. The award was not set aside for any small business designation. This contract is likely part of Abbott's broader support for federal agencies' COVID-19 testing and diagnostic needs, as the company is a major supplier of rapid antigen tests and other diagnostic products to the Department of Veterans Affairs and Department of Defense.
Quick answers
Who was awarded contract HHSI244201700022G?
HHSI244201700022G was awarded to Abbott Rapid DX North America LLC by Indian Health Service (Department of Health and Human Services) on October 3, 2016.
How much is contract HHSI244201700022G worth?
The government has obligated $33,480 on HHSI244201700022G. Its current value, with exercised options, is $88,480.
Is contract HHSI244201700022G an order under another contract?
Yes. HHSI244201700022G is a delivery order under V797P5076B, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract HHSI244201700022G competed?
The extent of competition for HHSI244201700022G was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award